15
Participants
Start Date
March 31, 2023
Primary Completion Date
November 30, 2026
Study Completion Date
March 31, 2027
Chemotherapy
Patients will receive continuation of second or initiate third-line chemotherapy regimen at the discretion and decision of treating oncologist.
Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
"EUS-RFA will be delivered using the EUSRA RF Electrode, which is a sterile, single-use electrosurgical accessory for coagulation and ablation of soft tissue when used in conjunction with compatible radio frequency generator (VIVA Combo RF Generator).~The device will be used during a routine EUS, which is a minimally invasive procedure used to assess gastrointestinal diseases. Each EUS-RFA procedure will last approximately 60 minutes."
RECRUITING
Tisch Hospital, New York
Taewoong Medical
UNKNOWN
NYU Langone Health
OTHER